Smaller sized doses for perioral treatment than for higher facial apps are utilised because the oral musculature responds more strongly to the same BTX-A dosing. Just one preparing of botulinum toxin type B (MyoBloc®/NeuroBloc®) exists. Its sole indication and FDA acceptance lies in treatments of cervical dystonia. Whilst nasolabial folds